Women in Ghana can access safe abortions: why are so many still using unsafe methods?

March 5, 2026
D. Yaw Atiglo, Charlotte Abra Esime Ofori

Ghana’s abortion law is relatively liberal. Abortion is legally permitted in the first trimester when a pregnancy endangers the mother’s life or physical or mental health, or when it is due to rape or incest. Thus, medication abortion has become more widely available.

Medication abortion involves the use of mifepristone and misoprostol pills which stop pregnancy and enable the uterus to expel it naturally. When used correctly and with proper guidance it is an acceptable, effective and safe method.

Continued: https://theconversation.com/women-in-ghana-can-access-safe-abortions-why-are-so-many-still-using-unsafe-methods-274991

ARGENTINA – Court intervention puts abortion drug supply under scrutiny

Federal court orders Health Ministry to publicise a collective constitutional amparo action seeking to guarantee access to abortion.

Feb 27, 2026
Barbara Komarovsky

A dispute over the supply of abortion medication has escalated into a broader constitutional battle over whether Argentina’s government is upholding the country’s 2020 abortion law.

Federal Civil, Commercial and Contentious-Administrative Court No. 2 of La Plata has instructed the government, through the Health Ministry led by Mario Lugones, to publicise a collective amparo – a legal mechanism in Argentina that allows individuals or groups to seek urgent judicial protection of constitutional rights – seeking to guarantee access to abortion.

Continued: https://www.batimes.com.ar/news/argentina/collective-amparo-to-guarantee-access-to-abortions.phtml

27.02.2026

News

Centro de Estudios Legales y Sociales

Civil association La Ciega

Voluntary Termination of Pregnancy Law

Australia – An important anniversary in the history of women’s reproductive healthcare

Michael Carrette, Caroline de Costa, Philip Goldstone, Mukesh Haikerwal
Issue 6 / 16 February 2026

February 2026 marks the twentieth anniversary of the overturning of the Harradine Amendment by the Federal Parliament in 2006. Thanks to the efforts of many people across the country, this parliamentary action opened the way for a cascade of reforms in abortion care for Australian women.

The 1996 Amendment to the 1989 Therapeutic Goods Act was a political measure initiated by Brian Harradine, independent senator for Tasmania, who held the balance of power in the Senate during the Howard government and who was a hostile opponent of abortion. At the time, mifepristone (better known then as RU486) had been used in Australia only for a small clinical trial by Monash professor David Healy. Harradine made a deal with then Prime Minister, John Howard — he would support Howard’s bill to privatise Telstra and in return Howard would bring in legislation forbidding the import, manufacture or use of mifepristone in Australia without the express permission of the Health Minister. The Amendment was passed and had the effect of completely blocking efforts to introduce mifepristone for medical abortion in Australia, despite increasing use of mifepristone in many overseas countries and its proven safety.

Continued: https://insightplus.mja.com.au/2026/6/an-important-anniversary-in-the-history-of-womens-reproductive-healthcare/

America’s abortion wars: inside the clinic on the front line

Since the overturning of Roe v Wade in 2022, abortion is illegal in 13 US states. New Mexico has become the nearest place for many women to terminate a pregnancy — if they can get past the religious activists on a mission to change their minds

George Grylls
Friday January 16 2026

Haley Nathan, 19, writes down the details of women’s cars on a clipboard outside an abortion clinic in New Mexico, braced for the day ahead. New Mexico is the closest option for any Texan woman to receive an abortion since the overturning of Roe v Wade in June 2022.

She’s frequently yelled at, or shown the middle finger. “I try not to let it bother me because it’s gonna affect my performance on the sidewalk,” says Nathan, a young intern, fixated on the clinic’s door as she prepares herself for the hostility coming her way. “I like to say it’s not me who’s doing the work. It’s God in me. I step out, God steps in.”

Continued: https://archive.is/6FX9Y
(https://www.thetimes.com/us/news-today/article/abortion-roe-v-wade-h2j7j9lm9)

Study: FDA Regulation of Abortion Drug Mifepristone from 2011 to 2023 Shaped by Evidence and Caution

Researchers reviewed hundreds of internal FDA documents obtained under FOIA

12-Jan-2026
by Johns Hopkins Bloomberg School of Public Health

An analysis of internal Food and Drug Administration documents by researchers at the Johns Hopkins Bloomberg School of Public Health finds that the agency generally followed cautious and evidence-based recommendations from staff scientists regulating the abortion drug mifepristone over a critical 12-year period.

The findings were published online January 12 in JAMA.

Continued: https://www.newswise.com/articles/study-fda-regulation-of-abortion-drug-mifepristone-from-2011-to-2023-shaped-by-evidence-and-caution/?ad2f=1&aid=841596

12.01.2026

Research

abortion pills are safe

Anna Levashkevich

Food and Drug Administration

G. Caleb Alexander

Joanne Rosen

Johns Hopkins Bloomberg School of Public Health

US abortion pill access under fire: Lawsuits and regulatory battles to watch in 2026

By Daniel Wiessner
January 5, 2026

Since the U.S. Supreme Court rolled back the constitutional right to abortion in 2022, nearly half of U.S. states have banned or severely restricted the procedure, driving a surge in medication abortion - now used in more than 60% of abortions nationwide.

That has fueled a new wave of legal battles, with Republican-led states and conservative groups pressing to curb access to the abortion drug mifepristone, while providers and Democratic-led states push to expand it. Here's a look at the key lawsuits and regulatory fights whose outcomes could impact access to the drug in the year ahead:

Continued: https://www.reuters.com/legal/government/us-abortion-pill-access-under-fire-lawsuits-regulatory-battles-watch-2026-2026-01-05/

05.01.2026

Commentary

FDA

Food and Drug Administration

2025 Was a Year of Chaos for Reproductive Rights Under the Trump Administration

Project 2025 initiated a war on reproductive rights that could escalate into even higher gear in 2026.

By Lauren Rankin , Truthout
December 27, 2025

With a decidedly anti-choice Trump administration taking office at its start, 2025 was poised to be yet another brutal year for abortion rights. Advocates feared the imminent resurgence of the Comstock Act, an 1873 law that made it a criminal offense to share contraceptives, abortifacients, and information about either across state lines or through the mail.

As of now, the last month of this very difficult political year, that is yet to happen.

Continued: https://truthout.org/articles/2025-was-a-year-of-chaos-for-reproductive-rights-under-the-trump-administration/

Telemedicine abortion is winning — and that terrifies the right

by Julie F. Kay, opinion contributor
Dec 21, 2025

As we wrap up the year, let’s decree 2025 a glass-half-full year for abortion rights. The year’s headlines were consumed by doom and gloom coverage. From hits against Planned Parenthood to increasingly restrictive anti-abortion laws passing in red states, and threats to proven-safe abortion medications, the post-Roe landscape certainly appeared bleak.

Yet while news cycles focused on abortion bans and restrictions, a quiet revolution happened. Telemedicine abortion transformed the geography of abortion access nationwide. Although most pro-choice Americans remain unaware that telemedicine abortion is an option, patients seeking abortions have widely embraced it. More than a quarter of all abortions in the U.S. were provided via telemedicine in 2025.

Continued: https://thehill.com/opinion/healthcare/5653331-telemedicine-abortion-rights-2025/

21.12.2025

self-managed abortion

shield laws

telemedicine abortion

New Book Outlines Medication Abortion’s Origins—From ‘Chance’ Discovery to Decades of Clinical Tests and Global Approval

“Just Pills” author Rebecca Kelliher also discusses how the U.S. stacks up against Latin America on abortion rights, and what we can learn from the region’s fight for reproductive justice.

Dec 16, 2025
Catesby Holmes

The abortion drug mifepristone has transformed abortion care in the U.S. since its approval by the Food and Drug Administration 25 years ago.

…Journalist Rebecca Kelliher’s recent book, Just Pills, traces the history of abortion medications, starting with misoprostol’s whispered origins among Brazilian women in the 1980s as a “pill that makes your period back” through decades of clinical trials and widespread use in almost 100 countries.

Rewire News Group spoke with Kelliher about abortion politics, the disinformation that swirls around reproductive rights, and inspiration from abroad.

Continued: https://rewirenewsgroup.com/2025/12/16/mifepristone-just-pills-rebecca-kelliher-book/

A Global Telehealth First: Women Help Women Begins Producing Abortion Pill Combipack

Dec 14, 2025
by Carrie N. Baker, Ms. Magazine

The feminist telehealth provider is cutting out pharmaceutical middlemen to make abortion safer, simpler and more accessible across borders.

Across much of the world, medical providers do not offer abortion because this care is criminalized, stigmatized or unfunded. As a result, an increasing number of women are accessing abortion pills outside of the formal medical system. At the center of this shift is Women Help Women, a global telehealth abortion service that supports self-managed abortion by providing abortion pills and information about how to use them, to women around the world, especially in places where abortion is restricted by law, stigma or lack of access.

Continued; https://msmagazine.com/2025/12/14/global-telehealth-women-help-women-mifepristone-misprostol-abortion-pills-combo-pack/